JP5462476B2 - Oral composition - Google Patents
Oral composition Download PDFInfo
- Publication number
- JP5462476B2 JP5462476B2 JP2008313535A JP2008313535A JP5462476B2 JP 5462476 B2 JP5462476 B2 JP 5462476B2 JP 2008313535 A JP2008313535 A JP 2008313535A JP 2008313535 A JP2008313535 A JP 2008313535A JP 5462476 B2 JP5462476 B2 JP 5462476B2
- Authority
- JP
- Japan
- Prior art keywords
- composition
- viscosity
- agar
- oral cavity
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 55
- 229920001817 Agar Polymers 0.000 claims description 32
- 235000010419 agar Nutrition 0.000 claims description 32
- 239000008272 agar Substances 0.000 claims description 31
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 23
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 21
- 235000010413 sodium alginate Nutrition 0.000 claims description 21
- 239000000661 sodium alginate Substances 0.000 claims description 21
- 229940005550 sodium alginate Drugs 0.000 claims description 21
- 235000010493 xanthan gum Nutrition 0.000 claims description 18
- 239000000230 xanthan gum Substances 0.000 claims description 18
- 229920001285 xanthan gum Polymers 0.000 claims description 18
- 229940082509 xanthan gum Drugs 0.000 claims description 18
- 239000002562 thickening agent Substances 0.000 claims description 10
- 239000003906 humectant Substances 0.000 claims description 6
- 230000003020 moisturizing effect Effects 0.000 claims description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims 1
- 235000012239 silicon dioxide Nutrition 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 210000000214 mouth Anatomy 0.000 description 41
- 239000007864 aqueous solution Substances 0.000 description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 18
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 18
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 18
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 239000004480 active ingredient Substances 0.000 description 10
- 235000013305 food Nutrition 0.000 description 10
- 239000000243 solution Substances 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000004909 Moisturizer Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 230000001333 moisturizer Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229940041672 oral gel Drugs 0.000 description 4
- 229960004063 propylene glycol Drugs 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- MOZDKDIOPSPTBH-UHFFFAOYSA-N Benzyl parahydroxybenzoate Chemical compound C1=CC(O)=CC=C1C(=O)OCC1=CC=CC=C1 MOZDKDIOPSPTBH-UHFFFAOYSA-N 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 1
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 description 1
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- CTEMZTQLPNKNKP-REGJXUDFSA-N Maltosyl trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 CTEMZTQLPNKNKP-REGJXUDFSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical class CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 206010048685 Oral infection Diseases 0.000 description 1
- 206010035669 Pneumonia aspiration Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- KPQJOKRSYYJJEL-VLQRKCJKSA-K [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O Chemical compound [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O KPQJOKRSYYJJEL-VLQRKCJKSA-K 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 201000009807 aspiration pneumonia Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229940034794 benzylparaben Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000451 gelidium spp. gum Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229940113094 isopropylparaben Drugs 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000003232 mucoadhesive effect Effects 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- -1 polyoxyethylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000979 synthetic dye Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- CCXAYLQLOLXXKE-DWJAGBRCSA-K trisodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-t Chemical compound [Na+].[Na+].[Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C([O-])=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O CCXAYLQLOLXXKE-DWJAGBRCSA-K 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 150000003752 zinc compounds Chemical class 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Description
本発明は、乾燥した口腔内にすばやく水分を供給することで口腔内の乾燥症状をやわらげたり、口腔内で乾燥し、こびりついた痰や汚れに水分をすばやく浸透させ、清掃しやすくするとともに、口腔内における組成物の滞留性を高め乾燥を予防したり、保湿剤などの活性成分を留めるための十分な粘度を有する口腔用組成物に関する。 The present invention provides quick moisture supply to the dry oral cavity to ease dry symptoms in the oral cavity, dry in the oral cavity, quickly permeate moisture and dirt stuck to the mouth, making it easier to clean, The present invention relates to a composition for oral cavity having sufficient viscosity for increasing the retention of the composition in the inside to prevent drying and retaining active ingredients such as a humectant.
近年、加齢とともに口腔に乾燥感を訴える患者が増加している。この原因としては、口腔内に分泌される唾液量が少なくなることや、口での呼吸が増えることが挙げられる。乾燥を感じた際、水を飲んだり飴をなめるなどの対処ができる患者は口腔の重度な乾燥にはいたらないが、要介護者など自分で口を湿らせることのできない患者、特に経管栄養にて生命維持が図られ、経口摂取が途絶えている患者では、口腔内が過度に乾燥し、痰や汚れが口腔内にへばりついたり、口腔粘膜がひび割れたりといった症状が現れる。 In recent years, the number of patients who complain of dryness in the oral cavity is increasing with aging. This may be due to a decrease in the amount of saliva secreted into the oral cavity or an increase in breathing in the mouth. Patients who can take water and lick their wrinkles when they feel dry do not lead to severe dryness of the oral cavity, but patients who need to be moistened by themselves, such as those requiring care, especially tube feeding In patients whose life expectancy has been reduced and oral intake has stopped, symptoms such as excessive dryness of the oral cavity, wrinkles and dirt clinging to the oral cavity, and cracking of the oral mucosa appear.
これらの症状の治療及び予防は、単に患者の不快感を改善するという点のみならず、近年では、口腔内常在菌のバランスを保ち、口腔カンジダのような口腔感染症や、誤嚥性肺炎の発症を予防する点からも重要視されている。したがって、患者の口腔の湿潤を回復させ、患者に負担を与えず円滑に汚染物の除去を行なうと共に、口腔ケア後の口腔乾燥を予防することのできる製品が求められている。 The treatment and prevention of these symptoms not only improves the patient's discomfort, but in recent years it has maintained the balance of oral resident bacteria, and oral infections such as oral Candida and aspiration pneumonia It is also regarded as important in terms of preventing the onset of the disease. Accordingly, there is a need for a product that can restore moisture in the patient's oral cavity, smoothly remove contaminants without burdening the patient, and prevent oral dryness after oral care.
現在、口腔内を潤す製品として、保湿剤を配合したスプレーや、ジェル状の保湿クリームが報告され、また市販されている。スプレータイプは使用が簡便であるが、液の粘性が低くなければスプレーから噴射されないため、口腔内にとどまる十分な粘度がなく、頻繁に使用する必要がある。このような欠点を改善するものとして、口腔粘膜上での内容物の滞留時間を延長を期待してチキソトロピー性を付与した組成物などが報告されている(例えば、特許文献1参照)が、製剤自体の保水率を高めているに過ぎず、乾燥した口腔内に水分を供給し潤いを広げたり、乾燥した汚れをふやかし、清掃しやすくするには十分とはいえない。 Currently, sprays containing moisturizers and gel-type moisturizing creams have been reported and are commercially available as products for moisturizing the oral cavity. The spray type is easy to use, but if the viscosity of the liquid is not low, it is not sprayed from the spray, so there is no sufficient viscosity to stay in the oral cavity and it is necessary to use it frequently. In order to improve such a defect, a composition imparted with thixotropy in the hope of extending the residence time of the contents on the oral mucosa has been reported (for example, see Patent Document 1). It only increases the water retention rate of itself, and it is not enough to supply moisture to the dry oral cavity to spread moisture, to soften dry dirt and to facilitate cleaning.
一方ジェル状の保湿クリームとしては、口腔潤滑剤としても使用しうる、ポリビニルピロリドンとアニオン性粘膜付着性物質とを含む口腔ケア組成物(例えば、特許文献2参照);唾液の代替物として使用しうる、熱可逆性ポリマーと生体接着性ポリマーとを含む熱可逆性組成物(例えば、特許文献3参照)などが報告されている。しかしながら、これらの組成物は、口腔内に保湿剤を留めることはできるが、ジェル内に水分を閉じ込めた状態で口腔内にとどまるため、乾燥した口腔内に水分を供給し潤いを広げたり、乾燥した汚れをふやかし、清掃しやすくするには時間がかかる。
本発明は、乾燥した口腔内にすばやく水分を供給することで口腔内の乾燥症状をやわらげたり、口腔内で乾燥し、こびりついた痰や汚れに水分をすばやく浸透させ、清掃しやすくするとともに、口腔内における組成物の滞留性を高め乾燥を予防したり、保湿剤などの活性成分を留めるための十分な粘度を有する口腔用組成物に関する。 The present invention provides quick moisture supply to the dry oral cavity to ease dry symptoms in the oral cavity, dry in the oral cavity, quickly permeate moisture and dirt stuck to the mouth, making it easier to clean, The present invention relates to a composition for oral cavity having sufficient viscosity for increasing the retention of the composition in the inside to prevent drying and retaining active ingredients such as a humectant.
食品・化粧品分野で一般に使用されている、カルボキシメチルセルロースナトリウム、アルギン酸ナトリウム、キサンタンガムのような増粘剤を含む水性組成物は、その粘度を上昇させるに従い組成物からの水分の滲出、すなわち組成物から口腔への水分の供与量は低下し、粘度10,000mPa・s(25℃)を越える前に水分を与える力はほぼ無くなってしまう。このように、<1>口腔内における滞留性を高め乾燥を予防したり、保湿剤などの活性成分を留めるための十分な粘度を組成物に付与することと、<2>組成物から口腔への水分を供給し、乾燥した口腔内を速やかに湿潤させること、を両立させるのは困難であった。 Aqueous compositions containing thickeners such as sodium carboxymethylcellulose, sodium alginate, and xanthan gum that are commonly used in the food and cosmetic field, exude moisture from the composition as its viscosity increases, i.e. from the composition The amount of moisture supplied to the oral cavity decreases, and the ability to give water before the viscosity exceeds 10,000 mPa · s (25 ° C.) is almost lost. In this way, <1> increasing the retention in the oral cavity to prevent drying, and imparting sufficient viscosity to the composition to retain active ingredients such as humectants, and <2> from the composition to the oral cavity It was difficult to achieve both of supplying water and quickly moistening the dried oral cavity.
本発明者らは、乾燥した口腔内を速やかに湿潤させることができるよう、一定の水分供給能を有し、かつ口腔内に保湿剤などの活性成分を留めるための十分な粘度を有する口腔用組成物を提供すべく鋭意検討した。その結果、医薬品・食品・化粧品分野で一般に使用されうる増粘剤と、寒天とを含み、25℃での粘度が10,000〜50,000mPa・sである組成物が、かかるを所望の性質を満たすことを見出し、本発明を完成させた。 The inventors of the present invention have a constant water supply ability and a sufficient viscosity for retaining an active ingredient such as a humectant in the oral cavity so that the dried oral cavity can be quickly moistened. Intense study was conducted to provide the composition. As a result, a composition containing a thickener that can be generally used in the fields of pharmaceuticals, foods and cosmetics and agar, and having a viscosity at 25 ° C. of 10,000 to 50,000 mPa · s has such desired properties. The present invention has been completed.
本発明の組成物は、25℃での粘度が10,000〜50,000mPa・sと高いにもかかわらず、一定の水分供給能を有する。したがって、乾燥した口腔内をすばやく潤し、乾燥した汚れに水分を浸透させ、患者に負担を与えることなく、汚れの除去を容易にする。一方で、本発明の組成物は、25℃での粘度が10,000〜50,000mPa・sと高いため、口腔内における滞留時間の延長が期待される。したがって、組成物自体が口腔内を覆うことによる乾燥の予防と共に、組成物に配合される保湿剤などの活性成分を留めることによる、口腔の乾燥状態やそれに伴う疾患の治療及び予防効果が期待される。 The composition of the present invention has a constant water supply ability despite its high viscosity at 25 ° C. of 10,000 to 50,000 mPa · s. Therefore, the dried oral cavity is quickly moistened, moisture is penetrated into the dried dirt, and the removal of the dirt is facilitated without giving a burden to the patient. On the other hand, since the viscosity of the composition of the present invention is as high as 10,000 to 50,000 mPa · s at 25 ° C., the residence time in the oral cavity is expected to be extended. Therefore, in addition to preventing dryness due to the composition itself covering the oral cavity, it is expected to have a therapeutic and preventive effect on the dryness of the oral cavity and associated diseases by retaining active ingredients such as a moisturizer incorporated in the composition. The
本発明の口腔用組成物に使用しうる寒天は、医薬品・食品・化粧品原料として市販されている、粉末状、顆粒状又はフレーク状のものであってよい。そのような寒天として、例えば、伊那食品工業株式会社製の伊那寒天CS、伊那寒天CSG、ウルトラ寒天AX−100、ウルトラ寒天イーナなどが挙げられる。寒天の配合量は、増粘剤と共に組成物の25℃での粘度が10,000〜50,000mPa・sとなるような量であれば特に限定されるものではないが、水分供給能や粘度の点から、組成物の重量を基準にして0.5質量%以上、5.0質量%以下の範囲であるのが好ましく、さらには1.0質量%以上、2.0質量%以下の範囲であるのが好ましい。 The agar that can be used in the oral composition of the present invention may be in the form of powder, granules, or flakes that are commercially available as raw materials for pharmaceuticals, foods, and cosmetics. Examples of such agar include Ina Agar CS, Ina Agar CSG, Ultra Agar AX-100, and Ultra Agar Ena manufactured by Ina Food Industry Co., Ltd. The amount of agar blended is not particularly limited as long as the viscosity at 25 ° C. of the composition together with the thickener is 10,000 to 50,000 mPa · s. From this point, it is preferably in the range of 0.5% by mass or more and 5.0% by mass or less based on the weight of the composition, and more preferably in the range of 1.0% by mass or more and 2.0% by mass or less. Is preferred.
本発明の口腔用組成物に使用しうる増粘剤は、医薬品・食品・化粧品原料として市販されているものであればよく、例えば、カラギーナン、グァーガム、ペクチン、カルボキシメチルセルロースナトリウム(CMC)、アルギン酸ナトリウム(アルギン酸Na)、キサンタンガムなどの増粘多糖類が挙げられる。増粘剤は、好ましくは、カルボキシメチルセルロースナトリウム、アルギン酸ナトリウム及びキサンタンガムからなる群から選択される1種以上である。増粘剤の配合量は、寒天と共に組成物の25℃での粘度が10,000〜50,000mPa・sとなるような量であれば特に限定されるものではないが、水分供給能や粘度の点から、組成物の重量を基準にして、0.05質量%以上、10.0質量%以下の範囲であるのが好ましく、さらには0.1質量%以上、5.0質量%以下の範囲であるのが好ましい。 The thickener that can be used in the composition for oral cavity of the present invention may be any one that is commercially available as a raw material for pharmaceuticals, foods and cosmetics, such as carrageenan, guar gum, pectin, sodium carboxymethylcellulose (CMC), sodium alginate. Examples include thickening polysaccharides such as (Na alginate) and xanthan gum. The thickener is preferably one or more selected from the group consisting of sodium carboxymethylcellulose, sodium alginate and xanthan gum. The blending amount of the thickener is not particularly limited as long as the viscosity at 25 ° C. of the composition together with agar is 10,000 to 50,000 mPa · s. From this point, it is preferable that it is in the range of 0.05% by mass or more and 10.0% by mass or less based on the weight of the composition, and further 0.1% by mass or more and 5.0% by mass or less. A range is preferred.
本発明の組成物には、さらにpH調整剤、矯味剤、防腐剤、香料、色素、可溶化剤、界面活性剤などの添加剤を、該組成物の水分供給能を損なわない範囲において配合してもよい。また本発明の組成物には、口腔の乾燥状態やそれに伴う疾患の治療及び予防効果を期待して、保湿剤、抗菌剤、ビタミン剤などの活性成分を配合してもよい。 In the composition of the present invention, additives such as a pH adjuster, a corrigent, a preservative, a fragrance, a pigment, a solubilizer, and a surfactant are further blended within a range that does not impair the water supply ability of the composition. May be. In addition, the composition of the present invention may contain active ingredients such as a moisturizer, an antibacterial agent and a vitamin agent in view of the dryness of the oral cavity and the treatment and prevention effects of the accompanying diseases.
本発明の組成物は口腔内で使用するものであるため、そのpHは、5.5〜8.0の範囲であるのが好ましい。本発明の組成物に使用しうるpH調整剤としては、食品に使用しうるものであれば特に限定されず、例えばリン酸、リン酸一水素ナトリウム、リン酸二水素ナトリウム、リン酸一水素カリウム、リン酸二水素カリウム、あるいはクエン酸、リンゴ酸、ピロリン酸、酒石酸、酢酸又はこれらの塩が挙げらる。これらの一種又は二種以上の組み合わせを適宜選択すればよい。 Since the composition of the present invention is used in the oral cavity, its pH is preferably in the range of 5.5 to 8.0. The pH adjuster that can be used in the composition of the present invention is not particularly limited as long as it can be used in foods. For example, phosphoric acid, sodium monohydrogen phosphate, sodium dihydrogen phosphate, potassium monohydrogen phosphate , Potassium dihydrogen phosphate, citric acid, malic acid, pyrophosphoric acid, tartaric acid, acetic acid, or salts thereof. What is necessary is just to select these 1 type, or 2 or more types of combinations suitably.
本発明の組成物に使用しうる矯味剤、防腐剤、香料、着色料、可溶化剤、界面活性剤などの添加剤としては、医薬品・食品・化粧品に使用しうるものであれば特に限定されない。例えば、矯味剤としては、サッカリン、サッカリンナトリウム、グリチルリチン酸二ナトリウム、グリチルリチン酸三ナトリウム、ショ糖、ブドウ糖、果糖、乳糖、ハチミツ、アスパルテーム、ステビア、スクラロース、キシリトール、イノシトール、トレハロース、D−ソルビトール、D−マンニトール、ラフィノース、ラクチュロース、ラクチトール、エリスリトール、還元パラチノース、パラチノース、パラチニット、アセスルファムK、マルトース、マルトシルトレハロース又はマルチトールが挙げられる。これらの一種又は二種以上の組み合わせを適宜選択すればよい。 Additives such as flavoring agents, preservatives, fragrances, coloring agents, solubilizers, surfactants and the like that can be used in the composition of the present invention are not particularly limited as long as they can be used in pharmaceuticals, foods, and cosmetics. . For example, as a flavoring agent, saccharin, sodium saccharin, disodium glycyrrhizinate, trisodium glycyrrhizinate, sucrose, glucose, fructose, lactose, honey, aspartame, stevia, sucralose, xylitol, inositol, trehalose, D-sorbitol, D- Examples include mannitol, raffinose, lactulose, lactitol, erythritol, reduced palatinose, palatinose, palatinit, acesulfame K, maltose, maltosyl trehalose or maltitol. What is necessary is just to select these 1 type, or 2 or more types of combinations suitably.
防腐剤としては、例えば、メチルパラベン、エチルパラベン、イソプロピルパラベン、プロピルパラベン、ブチルパラベン、イソブチルパラベン、ベンジルパラベンなどのパラベン(パラオキシ安息香酸エステル)類、フェノキシエタノール、エタノールなどのアルコール類、あるいはソルビン酸、安息香酸、デヒドロ酢酸、プロピオン酸又はこれらの塩などが挙げらる。これらの一種又は二種以上の組み合わせを適宜選択すればよい。 Examples of the preservative include parabens (paraoxybenzoic acid esters) such as methylparaben, ethylparaben, isopropylparaben, propylparaben, butylparaben, isobutylparaben and benzylparaben, alcohols such as phenoxyethanol and ethanol, or sorbic acid and benzoic acid. Examples thereof include acids, dehydroacetic acid, propionic acid, and salts thereof. What is necessary is just to select these 1 type, or 2 or more types of combinations suitably.
香料としては、l−メントール、ペパーミント、スペアミント又はフルーツ香料などが挙げられる。香料は、唾液分泌を刺激するという利点も有する。着色料としては、天然又は合成の色素、例えば、食用タール系色素、カラメル色素、クチナシ色素、アントシアニン色素、ベニバナ色素などが挙げられる。これらの一種又は二種以上の組み合わせを適宜選択すればよい。 Examples of the fragrance include l-menthol, peppermint, spearmint, and fruit fragrance. The perfume also has the advantage of stimulating salivation. Examples of the colorant include natural or synthetic dyes such as edible tar dyes, caramel dyes, gardenia dyes, anthocyanin dyes, safflower dyes, and the like. What is necessary is just to select these 1 type, or 2 or more types of combinations suitably.
可溶化剤は、本発明の組成物の基剤である水への上記添加剤や活性成分の溶解を促進することができるものであればよく、例として、プロピレングリコール、ジプロピレングリコール、ブチレングリコール、ポリエチレングリコールなどの多価アルコール類などを挙げることができる。また界面活性剤としては、ポリソルベート、ラウリル硫酸塩、ラウリン酸ポリグリセリル、ラウロイルサルコシン塩、ポリオキシエチレン硬化ヒマシ油、水添ヒマシ油などを挙げることができる。これらの一種又は二種以上の組み合わせを適宜選択すればよい。 Any solubilizing agent may be used as long as it can promote the dissolution of the additive and the active ingredient in water, which is the base of the composition of the present invention. Examples thereof include propylene glycol, dipropylene glycol, and butylene glycol. And polyhydric alcohols such as polyethylene glycol. Examples of the surfactant include polysorbate, lauryl sulfate, polyglyceryl laurate, lauroyl sarcosine salt, polyoxyethylene hydrogenated castor oil, and hydrogenated castor oil. What is necessary is just to select these 1 type, or 2 or more types of combinations suitably.
本発明の組成物にさらに配合しうる活性成分としての保湿剤もまた、医薬品・食品・化粧品に使用しうるものであれば特に限定されないが、例えば、アミノ酸又はその塩、ピロリドンカルボン酸;ムチン、ヒアルロン酸又はその塩、コンドロイチン硫酸などのムコ多糖類;グリセリン、プロピレングリコール、ブチレングリコール、ソルビトール、キシリトール又はポリエチレングリコールなどの多価アルコール類;チャエキスなどの天然エキス成分などを挙げることができる。これらの一種又は二種以上の組み合わせを適宜選択すればよい。 The humectant as an active ingredient that can be further blended in the composition of the present invention is not particularly limited as long as it can be used in pharmaceuticals, foods, and cosmetics. For example, amino acids or salts thereof, pyrrolidone carboxylic acid; mucin, Examples include mucopolysaccharides such as hyaluronic acid or salts thereof, chondroitin sulfate; polyhydric alcohols such as glycerin, propylene glycol, butylene glycol, sorbitol, xylitol, and polyethylene glycol; natural extract components such as tea extract. What is necessary is just to select these 1 type, or 2 or more types of combinations suitably.
抗菌剤としては、クロルヘキシジン、塩化セチルピリジニウム、亜鉛化合物又はトリクロサンなどが挙げられる。これらの一種又は二種以上の組み合わせを適宜選択すればよい。 Examples of the antibacterial agent include chlorhexidine, cetylpyridinium chloride, a zinc compound, and triclosan. What is necessary is just to select these 1 type, or 2 or more types of combinations suitably.
ビタミン剤としては、レチノイン酸、β−カロテンなどのビタミンA類、パントテン酸又はその塩類、ナイアシン、ビオチンなどのビタミンB類、アスコルビン酸又はその塩類、誘導体などのビタミンC類、α−トコフェロールなどのビタミンE類、葉酸などが挙げられる。これらの一種又は二種以上の組み合わせを適宜選択すればよい。 Examples of vitamins include vitamin A such as retinoic acid and β-carotene, pantothenic acid or salts thereof, vitamin B such as niacin and biotin, vitamin C such as ascorbic acid or salts and derivatives thereof, α-tocopherol and the like Vitamin E, folic acid, etc. are mentioned. What is necessary is just to select these 1 type, or 2 or more types of combinations suitably.
本発明の組成物は、水に寒天及び少なくとも1種の増粘剤、並びに添加剤及び/又は活性成分を配合することにより得られる。その際、かかる組成物は、25℃での粘度が10,000〜50,000mPa・sとなるように、好ましくは30,000〜45,000mPa・sとなるように、寒天及び増粘剤により適宜調整される。ここで粘度は、B型粘度計BL(株式会社東京計器製)で25℃にて測定した。 The composition of the present invention is obtained by blending agar and at least one thickener, and additives and / or active ingredients in water. In this case, the composition is agar and thickener so that the viscosity at 25 ° C. is 10,000 to 50,000 mPa · s, preferably 30,000 to 45,000 mPa · s. Adjust as appropriate. Here, the viscosity was measured at 25 ° C. with a B-type viscometer BL (manufactured by Tokyo Keiki Co., Ltd.).
本発明の口腔用組成物は、25℃での粘度が10,000〜50,000mPa・sと比較的高い。したがって一般に、口腔用のジェル状製品として提供されるのが好ましい。本発明の組成物は、患者自身あるいは介護者により、口腔内に手であるいはブラシやスポンジなどで適量を塗布して使用すればよい。 The oral composition of the present invention has a relatively high viscosity at 25 ° C. of 10,000 to 50,000 mPa · s. Therefore, it is generally preferred to be provided as a gel product for the oral cavity. The composition of the present invention may be used by applying an appropriate amount to the oral cavity by hand or with a brush or sponge by the patient himself or his / her caregiver.
〔水分供与量測定実験法〕
以下の各製造例により得られた試料の水分供与能を、以下の方法により測定した。
(1)ろ紙(東京ろ紙会社製、ADAVANTEC 5B(直径110mm))の中央に、直径5mmの穴の開いた金属製の板(直径22mm、厚み1.5mm)を置く。
(2)穴に25μLの各試料を入れ、室温で10分間静置する。
(3)金属板を静かに除き、ろ紙に水が吸収され変色した部分の直径を計測する。
[Experiment method of moisture supply measurement]
The water donating ability of the samples obtained in each of the following production examples was measured by the following method.
(1) A metal plate (diameter 22 mm, thickness 1.5 mm) having a hole with a diameter of 5 mm is placed in the center of a filter paper (manufactured by Tokyo Filter Paper Company, ADAVANTEC 5B (diameter 110 mm)).
(2) Put 25 μL of each sample into the hole and let stand at room temperature for 10 minutes.
(3) Gently remove the metal plate and measure the diameter of the part of the filter paper where the water is absorbed and discolored.
〔粘度測定法〕
粘度は、B型粘度計BL(株式会社東京計器製)を用い、25℃にて測定した。
[Viscosity measurement method]
The viscosity was measured at 25 ° C. using a B-type viscometer BL (manufactured by Tokyo Keiki Co., Ltd.).
〔例1〕
寒天(ウルトラ寒天AX−100、伊那食品工業株式会社製)の1.0wt%、1.5wt%、2.0wt%水溶液にカルボキシメチルセルロースナトリウム(CMC:CMCダイセル、ダイセル化学工業製)を0.5wt%、1.0wt%、1.5wt%となるよう加えていき、粘度、水分供与量を測定した。
[Example 1]
0.5 wt. Of sodium carboxymethylcellulose (CMC: CMC Daicel, manufactured by Daicel Chemical Industries) is added to 1.0 wt%, 1.5 wt%, and 2.0 wt% aqueous solution of agar (Ultra Agar AX-100, manufactured by Ina Food Industry Co., Ltd.). %, 1.0 wt%, and 1.5 wt% were added, and the viscosity and water supply amount were measured.
図1に、例1で調整した各試料の粘度の変化を示した。グラフ中、■は、CMC1.5wt%及びCMC2.0wt%水溶液における粘度の変化を示し、◆は、寒天1.0wt%+CMC0.5wt%水溶液;+CMC1.0wt%水溶液;+CMC1.5wt%水溶液における粘度の変化を示し、▲は、寒天1.5wt%+CMC0.5wt%水溶液;+CMC1.0wt%水溶液;+CMC1.5wt%水溶液における粘度の変化を示し、●は、寒天2.0wt%+CMC0.5wt%水溶液;+CMC1.0wt%水溶液;+CMC1.5wt%水溶液における粘度の変化を示している。それぞれCMCの配合量の増加と共に粘度が増加し、水分供与量が明らかに低下しているが、寒天とCMCとを併用したことにより、10,000mPa・sを超える粘度でも高い水分供与量を得ることができた。 FIG. 1 shows the change in viscosity of each sample prepared in Example 1. In the graph, ■ indicates the change in viscosity in CMC 1.5 wt% and CMC 2.0 wt% aqueous solution, and ◆ indicates viscosity in agar 1.0 wt% + CMC 0.5 wt% aqueous solution; + CMC 1.0 wt% aqueous solution; + CMC 1.5 wt% aqueous solution ▲ indicates agar 1.5 wt% + CMC 0.5 wt% aqueous solution; + CMC 1.0 wt% aqueous solution; + CMC 1.5 wt% aqueous solution viscosity change, ● indicates agar 2.0 wt% + CMC 0.5 wt% aqueous solution + CMC 1.0 wt% aqueous solution; + CMC 1.5 wt% aqueous solution shows the change in viscosity. The viscosity increases with the increase in the amount of CMC added, and the water supply amount is clearly reduced. By using agar and CMC in combination, a high water supply amount can be obtained even at a viscosity exceeding 10,000 mPa · s. I was able to.
〔例2〕
寒天(例1と同じ)の1.0wt%、1.5wt%、2.0wt%水溶液にアルギン酸ナトリウム(ダックアルギン酸NSPM、株式会社紀文フードケミファ製)を0.5wt%、1.0wt%、2.0wt%となるよう加えていき、粘度、水分供与量を測定した。図3に示すように、アルギン酸ナトリウムを寒天と併用することにより10,000mPa・sを超える粘度でも高い水分供与量を得ることができた。
[Example 2]
Sodium alginate (Duck alginate NSPM, manufactured by Kibun Food Chemifa Co., Ltd.) in an aqueous solution of 1.0 wt%, 1.5 wt% and 2.0 wt% of agar (same as Example 1) The viscosity and the amount of water supply were measured by adding 0.0 wt%. As shown in FIG. 3, by using sodium alginate in combination with agar, a high water supply amount could be obtained even at a viscosity exceeding 10,000 mPa · s.
図2に、例2で調整した各試料の粘度の変化を示した。グラフ中、■は、アルギン酸ナトリウム1.0wt%、2.0wt%及び4.0wt%水溶液における粘度の変化を示し、◆は、寒天1.0wt%+アルギン酸ナトリウム0.5wt%水溶液;+アルギン酸ナトリウム1.0wt%水溶液;+アルギン酸ナトリウム2.0wt%水溶液における粘度の変化を示し、▲は、寒天1.5wt%+アルギン酸ナトリウム0.5wt%水溶液;+アルギン酸ナトリウム1.0wt%水溶液;+アルギン酸ナトリウム2.0wt%水溶液における粘度の変化を示し、●は、寒天2.0wt%+アルギン酸ナトリウム0.5wt%水溶液;+アルギン酸ナトリウム1.0wt%水溶液;+アルギン酸ナトリウム2.0wt%水溶液における粘度の変化を示している。それぞれアルギン酸ナトリウムの配合量の増加と共に粘度が増加し、水分供与量が明らかに低下しているが、寒天とアルギン酸ナトリウムとを併用したことにより、10,000mPa・sを超える粘度でも高い水分供与量を得ることができた。 FIG. 2 shows the change in viscosity of each sample prepared in Example 2. In the graph, ■ indicates changes in viscosity in aqueous solutions of 1.0 wt%, 2.0 wt%, and 4.0 wt% sodium alginate, and ◆ indicates an aqueous solution of 1.0 wt% agar + 0.5 wt% sodium alginate; + sodium alginate 1.0 wt% aqueous solution: + Viscosity change in sodium alginate 2.0 wt% aqueous solution, ▲ indicates agar 1.5 wt% + sodium alginate 0.5 wt% aqueous solution; + sodium alginate 1.0 wt% aqueous solution; + sodium alginate The change in viscosity in a 2.0 wt% aqueous solution is shown, and ● represents the change in viscosity in agar 2.0 wt% + sodium alginate 0.5 wt% aqueous solution; + sodium alginate 1.0 wt% aqueous solution; + sodium alginate 2.0 wt% aqueous solution Is shown. Viscosity increases with increasing amount of sodium alginate, and the amount of water supply is clearly reduced. By using agar and sodium alginate in combination, the amount of water supply is high even at a viscosity exceeding 10,000 mPa · s. Could get.
〔例3〕
寒天(例1と同じ)の1.0wt%、1.5wt%、2.0wt%水溶液にキサンタンガム(サンエースNXG−S、三栄源エフ・エフ・アイ株式会社製)を0.2wt%、0.5wt%、1.0wt%となるよう加えていき、粘度、水分供与量を測定した。図3に示すように、アルギン酸ナトリウムを寒天と併用することにより10,000mPa・sを超える粘度でも高い水分供与量を得ることができた。
[Example 3]
Xanthan gum (San Ace NXG-S, Saneigen FFI Co., Ltd.) was added to 1.0 wt%, 1.5 wt%, and 2.0 wt% aqueous solutions of agar (same as Example 1). Viscosity and water supply were measured by adding 5 wt% and 1.0 wt%. As shown in FIG. 3, by using sodium alginate in combination with agar, a high water supply amount could be obtained even at a viscosity exceeding 10,000 mPa · s.
図3に、例3で調整した各試料の粘度の変化を示した。グラフ中、■は、キサンタンガム0.2wt%、0.5wt%、1.0wt%及び2.0wt%水溶液における粘度の変化を示し、◆は、寒天1.0wt%+キサンタンガム0.2wt%水溶液;+キサンタンガム0.5wt%水溶液;+キサンタンガム1.0wt%水溶液における粘度の変化を示し、▲は、寒天1.5wt%+キサンタンガム0.2wt%水溶液;+キサンタンガム0.5wt%水溶液;+キサンタンガム1.0wt%水溶液における粘度の変化を示し、●は、寒天2.0wt%+キサンタンガム0.2wt%水溶液;+キサンタンガム0.5wt%水溶液;+キサンタンガム1.0wt%水溶液における粘度の変化を示している。それぞれキサンタンガムの配合量の増加と共に粘度が増加し、水分供与量が明らかに低下しているが、寒天とキサンタンガムとを併用したことにより、10,000mPa・sを超える粘度でも高い水分供与量を得ることができた。 FIG. 3 shows the change in viscosity of each sample prepared in Example 3. In the graph, ■ indicates changes in viscosity in xanthan gum 0.2 wt%, 0.5 wt%, 1.0 wt%, and 2.0 wt% aqueous solutions, and ◆ indicates agar 1.0 wt% + xanthan gum 0.2 wt% aqueous solution; + Xanthan gum 0.5 wt% aqueous solution; + Change in viscosity in xanthan gum 1.0 wt% aqueous solution, ▲ indicates agar 1.5 wt% + xanthan gum 0.2 wt% aqueous solution; + xanthan gum 0.5 wt% aqueous solution; The change in viscosity in a 0 wt% aqueous solution is shown, and the black circle shows the change in viscosity in an agar 2.0 wt% + xanthan gum 0.2 wt% aqueous solution; + xanthan gum 0.5 wt% aqueous solution; + xanthan gum 1.0 wt% aqueous solution. The viscosity increases with the increase in the amount of xanthan gum, and the water supply amount is clearly reduced. However, by using agar and xanthan gum in combination, a high water supply amount can be obtained even at a viscosity exceeding 10,000 mPa · s. I was able to.
〔例4〕
口腔用ジェル組成物の調製
[Example 4]
Preparation of oral gel composition
上記組成の口腔用ジェル組成物を、以下の方法に従って調製した:
(1)寒天を適量の精製水に加え、撹拌しながら80℃に加熱し溶解させ、得られた溶液を撹拌しながら40℃まで冷却した;
(2)プロピレングリコール、グリセリン中に、メチルパラベン、l−メントールを溶解し、さらにそこにアルギン酸ナトリウムとキサンタンガムを分散させた;
(3)その他の成分を、残りの精製水に溶解させ、得られた溶液を前記(2)で得られた分散液に加え、撹拌、溶解させた;
(4)40℃に保持した前記(1)の溶液に、前記(3)の溶液を加えて撹拌しながら室温まで冷却した。
An oral gel composition of the above composition was prepared according to the following method:
(1) Agar was added to an appropriate amount of purified water, heated to 80 ° C. with dissolution and dissolved, and the resulting solution was cooled to 40 ° C. with stirring;
(2) Methylparaben and l-menthol were dissolved in propylene glycol and glycerin, and sodium alginate and xanthan gum were further dispersed therein;
(3) Other components were dissolved in the remaining purified water, and the resulting solution was added to the dispersion obtained in (2) above, stirred and dissolved;
(4) The solution of (3) was added to the solution of (1) maintained at 40 ° C. and cooled to room temperature while stirring.
〔例5〕
口腔用ジェル組成物の調製
[Example 5]
Preparation of oral gel composition
上記組成の口腔用ジェル組成物を、以下の方法に従って調製した:
(1)寒天を適量の精製水に加え、撹拌しながら80℃に加熱し溶解させ、得られた溶液を撹拌しながら40℃まで冷却した;
(2)プロピレングリコール、グリセリン中に、メチルパラベンを溶解させ、さらにそこにCMCを分散させた;
(3)その他の成分を、残りの精製水に溶解させ、得られた溶液を前記(2)で得られた分散液に加え、撹拌、溶解させた;
(4)40℃に保持した前記(1)の溶液に、前記(3)の溶液を加えて撹拌しながら室温まで冷却した。
An oral gel composition of the above composition was prepared according to the following method:
(1) Agar was added to an appropriate amount of purified water, heated to 80 ° C. with dissolution and dissolved, and the resulting solution was cooled to 40 ° C. with stirring;
(2) methylparaben was dissolved in propylene glycol and glycerin, and CMC was further dispersed therein;
(3) Other components were dissolved in the remaining purified water, and the resulting solution was added to the dispersion obtained in (2) above, stirred and dissolved;
(4) The solution of (3) was added to the solution of (1) maintained at 40 ° C. and cooled to room temperature while stirring.
本発明の組成物は、25℃での粘度が10,000〜50,000mPa・sと高いにもかかわらず、一定の水分供給能を有する。したがって、乾燥した口腔内をすばやく潤し、乾燥した汚れに水分を浸透させ、患者に負担を与えずに、汚れの除去を容易にする。一方で、本発明の組成物は、25℃での粘度が10,000〜50,000mPa・sと高いため、口腔内における滞留時間の延長が期待される。したがって、組成物自体が口腔を覆うことによる乾燥の予防と共に、組成物に配合される保湿剤などの活性成分を留めることによる、口腔状態やそれに伴う疾患の治療及び予防効果が期待される。 The composition of the present invention has a constant water supply ability despite its high viscosity at 25 ° C. of 10,000 to 50,000 mPa · s. Therefore, the dried oral cavity is quickly moistened, moisture is penetrated into the dried dirt, and the removal of the dirt is facilitated without burdening the patient. On the other hand, since the viscosity of the composition of the present invention is as high as 10,000 to 50,000 mPa · s at 25 ° C., the residence time in the oral cavity is expected to be extended. Therefore, in addition to prevention of dryness due to the composition itself covering the oral cavity, the therapeutic and preventive effects of oral conditions and associated diseases are expected by retaining active ingredients such as a moisturizer blended in the composition.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008313535A JP5462476B2 (en) | 2008-12-09 | 2008-12-09 | Oral composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008313535A JP5462476B2 (en) | 2008-12-09 | 2008-12-09 | Oral composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010138080A JP2010138080A (en) | 2010-06-24 |
JP5462476B2 true JP5462476B2 (en) | 2014-04-02 |
Family
ID=42348537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008313535A Active JP5462476B2 (en) | 2008-12-09 | 2008-12-09 | Oral composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5462476B2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5440408B2 (en) | 2010-06-17 | 2014-03-12 | セイコーエプソン株式会社 | Board module and printer |
JP5730041B2 (en) * | 2011-01-28 | 2015-06-03 | 日本ゼトック株式会社 | Oral composition |
JP5924998B2 (en) * | 2012-03-16 | 2016-05-25 | 日本ゼトック株式会社 | Gel oral composition |
JP6100575B2 (en) * | 2013-03-27 | 2017-03-22 | ライオン株式会社 | Oral composition |
JP6341797B2 (en) * | 2014-08-08 | 2018-06-13 | アサヒグループ食品株式会社 | Oral composition and oral preparation |
JP2016204330A (en) * | 2015-04-27 | 2016-12-08 | サンスター株式会社 | Composition for preparing tongue coating removal gel and tongue coating removal gel |
EP3982913A1 (en) | 2019-06-14 | 2022-04-20 | The Procter & Gamble Company | Leave-on oral care compositions |
EP3982912A1 (en) | 2019-06-14 | 2022-04-20 | The Procter & Gamble Company | Leave-on oral care compositions |
EP3982917A1 (en) | 2019-06-14 | 2022-04-20 | The Procter & Gamble Company | Leave-on oral care compositions |
WO2020248229A1 (en) * | 2019-06-14 | 2020-12-17 | The Procter & Gamble Company | Leave-on oral care compositions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3442808B2 (en) * | 1993-01-26 | 2003-09-02 | 日本ゼトック株式会社 | Dentifrice composition |
JP3545162B2 (en) * | 1997-03-05 | 2004-07-21 | 株式会社資生堂 | Oral composition |
JP2002029952A (en) * | 2000-05-11 | 2002-01-29 | Takayuki Kodama | Composition for dentifrice |
-
2008
- 2008-12-09 JP JP2008313535A patent/JP5462476B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2010138080A (en) | 2010-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5462476B2 (en) | Oral composition | |
DE60212673T2 (en) | COMPOSITIONS FOR THE TREATMENT OF XEROSTOMY AND TREATMENT OF RELATED DISEASES | |
JP5730041B2 (en) | Oral composition | |
JP2012153619A (en) | Composition for oral cavity | |
JP5233399B2 (en) | Oral spray composition and oral preparation | |
JP2022000420A (en) | Oral cavity composition | |
JP6795316B2 (en) | Oral care composition containing L-aspartic acid or a salt thereof, and nicotinamide. | |
JP2013129641A (en) | Composition for oral cavity and foul breath inhibitor | |
JP2013184971A (en) | Oral cavity care product blended with cyclodextrin | |
JP4909809B2 (en) | Artificial saliva | |
JP7431516B2 (en) | Oral composition | |
JP2005200327A (en) | Intraoral dryness-treating composition | |
JP2014139163A (en) | Body fluid secretion promoter | |
JP3690442B2 (en) | Salivary secretion promoter, oral composition and denture stabilizer | |
JP4804420B2 (en) | Artificial saliva | |
JP4808986B2 (en) | Essence dosage form topical skin preparation | |
KR100564231B1 (en) | Toothpaste composition comprising soft bead | |
JP6472722B2 (en) | Salivary secretagogue for oral administration | |
FR3010634A1 (en) | PHARMACEUTICAL COMPOSITIONS BASED ON VEGETABLE SURFACTANTS FOR THE TREATMENT OF HYPOSIALIE | |
EP2790653B1 (en) | Oral care composition | |
JP7318082B2 (en) | glycative stress inhibitor | |
JP5404424B2 (en) | Oral composition | |
JP2007291117A (en) | Artificial saliva | |
JP7058093B2 (en) | Mucosal irritation / bitterness inhibitor and oral composition | |
JP2022163809A (en) | Improver of oral bacterial flora |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111007 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130121 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130212 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130402 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131203 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131217 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140114 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140117 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5462476 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |